These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16222995)

  • 1. [Diagnosis of malignant colorectal neoplasms by means of molecular genetic analysis of fecal DNA].
    Lantsov VA; Vostriukhina OA
    Vopr Onkol; 2005; 51(2):167-72. PubMed ID: 16222995
    [No Abstract]   [Full Text] [Related]  

  • 2. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
    Onouchi S; Matsushita H; Moriya Y; Akasu T; Fujita S; Yamamoto S; Hasegawa H; Kitagawa Y; Matsumura Y
    Anticancer Res; 2008; 28(1A):145-50. PubMed ID: 18383838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá G
    Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fecal DNA analysis--future method for colorectal cancer screening?].
    Olsson L
    Lakartidningen; 2004 Nov; 101(47):3762-5. PubMed ID: 15609528
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fecal methylated DNA for the detection of colorectal cancer].
    von Delius S; Jung A; Schmid RM
    Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
    [No Abstract]   [Full Text] [Related]  

  • 6. Are we getting closer to molecular population screening for colorectal cancer?
    Rennert G
    J Natl Cancer Inst; 2009 Jul; 101(13):902-3. PubMed ID: 19535778
    [No Abstract]   [Full Text] [Related]  

  • 7. A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis.
    Matsushita H; Matsumura Y; Moriya Y; Akasu T; Fujita S; Yamamoto S; Onouchi S; Saito N; Sugito M; Ito M; Kozu T; Minowa T; Nomura S; Tsunoda H; Kakizoe T
    Gastroenterology; 2005 Dec; 129(6):1918-27. PubMed ID: 16344060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stool DNA: a viable option for colorectal cancer screening.
    Hardison DM; Shuber AP
    Gastroenterology; 2005 Dec; 129(6):2128-9; author reply 2129. PubMed ID: 16344091
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular stool screening for cancer diagnosis].
    Horn C; Parker D
    Tidsskr Nor Laegeforen; 2007 Feb; 127(3):321; author reply 321-2. PubMed ID: 17279119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular stool screening for cancer diagnosis].
    Søreide K
    Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2684-5. PubMed ID: 17057771
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ras-oncogene detection in feces of patients with colorectal tumors].
    Swinkels DW; de Kok J; van Muijen GN; Willems JL
    Ned Tijdschr Geneeskd; 1996 Mar; 140(9):510-1. PubMed ID: 8628444
    [No Abstract]   [Full Text] [Related]  

  • 12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer by stool DNA analysis.
    Lancet; 1992 May; 339(8802):1141-2. PubMed ID: 1349371
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved fecal DNA test for colorectal cancer screening.
    Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
    Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the DNA point mutation of colorectal cancer cells isolated from feces stored under different conditions.
    Koga Y; Yasunaga M; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
    Jpn J Clin Oncol; 2009 Jan; 39(1):62-9. PubMed ID: 19042945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stool test for colorectal cancer screening--it's time to move!
    Loitsch SM; Shastri Y; Stein J
    Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An electrophoretic capture method for efficient recovery of rare sequences from heterogeneous DNA.
    Kent Moore J; Smith JA; Whitney DH; Durkee KH; Shuber AP
    Biotechniques; 2008 Mar; 44(3):363-74. PubMed ID: 18361790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
    Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
    Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.